New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 19, 2014
16:00 EDTTSLA, AA, HD, TWTR, GILD, AAPL, EBAY, NFLX, PBROptions Update; August 19, 2014eBay
iPath S&P 500 VIX Short-Term Futures down 28c to 27.52. Option volume leaders: AAPL C HD PBR GILD AA NFLX TWTR TSLA EBAY according to Track Data.
News For AAPL;HD;PBR;GILD;AA;NFLX;TWTR;TSLA;EBAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>
July 15, 2015
13:52 EDTTWTRSoftbank COO says would be interested in Twitter 'at right price,' Fortune says
Subscribe for More Information
13:23 EDTEBAYGoogle unveils Purchases on Google, other shopping features
Subscribe for More Information
13:01 EDTNFLXEarnings Watch: Netflix shares trading up 45% since last earnings report
Subscribe for More Information
12:38 EDTAAPLGundlach says out of Apple position
Subscribe for More Information
12:18 EDTTWTRTwitter rolls out data dashboard for all users
In a blog post the company said: "Today, we’re continuing to roll out to all users the Twitter data dashboard — a new tool to help you monitor and manage your account....Now, your Twitter data dashboard — which you can access from the settings menu on twitter.com — shows your account activation details, the devices that have accessed your account and your recent login history. With this information, you can quickly review your account activity and verify that everything looks the way it should." Reference Link
11:35 EDTNFLXNetflix to support Charter's acquisition of Time Warner Cable, Bloomberg says
Subscribe for More Information
11:27 EDTNFLXNetflix July volatility elevated into Q2 and outlook
Netflix July call option implied volatility is at 133, August is at 49, September is at 42, compared to its 52-week range of 16 to 39, suggesting large near term price movement into the expected release of Q2 results today.
11:19 EDTNFLXNetflix technical commentary ahead of earnings
Subscribe for More Information
11:01 EDTAAPLApple introduces new iPod touch, unveils new colors for iPod models
Subscribe for More Information
10:04 EDTNFLXNetflix July 99.64 straddle priced for 9% movement into Q2
Subscribe for More Information
09:53 EDTAAPLHSBC UK says Apple Pay support coming within 2 weeks, Apple Insider says
HSBC UK (HSBC) said that Apple Pay (AAPL) support is in its final testing and availability will be coming within two weeks, reports Apple Insider. An HSBC spokesperson said, "We are excited to be one of a small number of Apple Pay launch partners. We have been working closely with Apple and are now properly reviewing and testing our systems before launching in two weeks." Reference Link
09:32 EDTNFLX, AAPLActive equity options trading on open
Active equity options trading on open: AAPL FB BAC RCPT MU YUM NFLX CELG
07:58 EDTGILDAnalysts break down impact of $7.2B Receptos buyout
After Celgene (CELG) announced last night that the company has agreed to acquire Receptos (RCPT) for $232 per share in cash, or a total of about $7.2B net of cash acquired, research firms have chimed in with their opinions on how the proposed deal may impact others in the biotech space. Receptos key asset is Ozanimod, which is being studied in Phase III trials for relapsing multiple sclerosis and ulcerative colitis. DERIVATIVE CALLS: Piper Jaffray analyst Edward Tenthoff told investors that he views Celgene's deal for Receptos as good for Arena Pharmaceuticals (ARNA). The analyst notes that Arena's APD334 is already showing dose-dependent decreases in circulating lymphocyte counts and that the company will initiate Phase II studies in ulcerative colitis and Crohn's disease this year. Tenthoff reiterates an Overweight rating and $7.50 price target on Arena, which has a market capitalization around $1B and closed yesterday up 8c to $4.47. In its own note to investors this morning, Nomura said Celgene's deal could put downward pressure on Biogen's (BIIB) long-term multiple sclerosis estimates. Nomura's M. Ian Somaiya contended that one-year Phase II efficacy data for Ozanimod looked as good as Novartis’s (NVS) Gilenya and Biogen's Tecfidera’s Phase III at year 2. Somaiya also wondered if rival Gilead (GILD) could be "looking for something bigger" than Receptos for its own deal, telling investors that the firm views Incyte (INCY) as Gilead's most likely takeout target. Incyte's shares closed up $4.46 at $117.46 yesterday, giving the company a market cap of about $20B. RIVAL BID?: Wedbush analyst Liana Moussatos believes another bidder may seek to acquire Receptos, noting that she previously estimated Receptos could be valued at $348 per share, or about $10.9B, in a buyout. Moussatos noted that Celgene said it expects annual peak sales for Ozanimod to reach about $4B-$6B for RMS and UC, making its acquisition price of $7.2BN only a bit more than about 1X peak sales without accounting for other possible indications or the rest of its pipeline. Moussatos told investors she sees "plenty" of potential upside to justify a rival bidder stepping in and reiterated the firm's Outperform rating on Receptos shares. PRICE ACTION: In pre-market trading, Receptos rose 10% to $228.61 while Gilead gained 1.4% to about $119 per share.
07:38 EDTNFLXNetflix July volatility increases into Q2 and outlook
Netflix July call option implied volatility is at 108, August is at 49, September is at 42, compared to its 52-week range of 16 to 39, suggesting large near term price movement into the expected release of Q2 results today.
07:04 EDTEBAYITUS enters into settlement and license agreement with eBay, Vendio, Auctiva
ITUS (ITUS) announced that its wholly owned subsidiary, Auction Acceleration Corporation, has entered into a Settlement and License Agreement with eBay (EBAY), Auctiva, LLC, and Vendio Services, LLC. The Settlement and License Agreement resolves a lawsuit between the parties that was filed on September 8, 2014 in The United States District Court for the Northern District of California, which will be dismissed. AAC owns the rights to patents that cover presentation and cross selling technologies enabling auction sellers to cross-sell and upsell additional items to interested buyers, resulting in incremental sales and higher yields per transaction.
06:39 EDTAAPLApple to release new iPod touch, 9to5Mac reports
Subscribe for More Information
06:33 EDTAAPLApple 'in touch' with Iranian distributors to sell products there, WSJ reports
Subscribe for More Information
06:32 EDTTSLATesla buys 2,000 extra acres for Nevada factory, WSJ reports
Tesla has almost tripled its land holdings in Nevada recently, having bought nearly 2,000 additional acres near Reno as it works on a factory intended to build batteries for electric cars and stationary backup batteries, the Wall Street Journal reports. Tesla originally bought 1,000 acres last year, though that agreement including options to purchase additional land, the report says. Reference Link
06:29 EDTTWTREvan Williams would leave Twitter board if 3 former CEOs not preferred, WSJ says
Subscribe for More Information
05:52 EDTPBRStocks with implied volatility movement; PBR S
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use